Barauskas Ona, Xing Weimei, Aguayo Esmeralda, Willkom Madeleine, Sapre Annapurna, Clarke Michael, Birkus Gabriel, Schultz Brian E, Sakowicz Roman, Kwon HyockJoo, Feng Joy Y
Gilead Sciences, Inc., Foster City, California, United States of America.
PLoS One. 2017 Oct 11;12(10):e0185998. doi: 10.1371/journal.pone.0185998. eCollection 2017.
Influenza polymerase is a heterotrimer protein with both endonuclease and RNA-dependent RNA polymerase (RdRp) activity. It plays a critical role in viral RNA replication and transcription and has been targeted for antiviral drug development. In this study, we characterized the activity of recombinant RdRp purified at 1:1:1 ratio in both ApG-primed RNA replication and mRNA-initiated RNA transcription. The heterotrimer complex showed comparable activity profiles to that of viral particle derived crude replication complex, and in contrast to the crude replication complex, was suitable for detailed mechanistic studies of nucleotide incorporation. The recombinant RdRp was further used to examine distinct modes of inhibition observed with five different nucleotide analog inhibitors, and the apparent steady-state binding affinity Kapp was measured for selected analogs to correlate antiviral activity and enzymatic inhibition with substrate efficiency.
流感病毒聚合酶是一种具有核酸内切酶和RNA依赖性RNA聚合酶(RdRp)活性的异源三聚体蛋白。它在病毒RNA复制和转录中起关键作用,并且一直是抗病毒药物开发的靶点。在本研究中,我们对以1:1:1比例纯化的重组RdRp在ApG引发的RNA复制和mRNA起始的RNA转录中的活性进行了表征。该异源三聚体复合物显示出与病毒颗粒来源的粗制复制复合物相当的活性谱,并且与粗制复制复合物不同,它适用于核苷酸掺入的详细机制研究。重组RdRp进一步用于研究五种不同核苷酸类似物抑制剂观察到的不同抑制模式,并测量了选定类似物的表观稳态结合亲和力Kapp,以将抗病毒活性和酶抑制与底物效率相关联。